187. Kabuki syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 9 - (DrugBank : 2) / Drug target genes : 2 - Drug target pathways : 11
Kabuki syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 187 | Kabuki syndrome | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 3.000 |
| 2 | Amyotrophic lateral sclerosis | 3.000 |
| 179 | Williams syndrome | 1.481 |
| 74 | Prolactin secreting pituitary adenoma | 1.417 |
| 254 | Porphyria | 1.404 |
| 21 | Mitochondrial disease | 1.362 |
| 140 | Dorabe syndrome | 1.361 |
| 206 | Fragile X syndrome | 1.358 |
| 75 | Cushing disease | 1.355 |
| 156 | Rett syndrome | 1.351 |
| 8 | Huntington disease | 1.349 |
| 299 | Cystic fibrosis | 1.347 |
| 46 | Malignant rheumatoid arthritis | 1.341 |
| 6 | Parkinson disease | 1.340 |
| 191 | Werner syndrome | 1.000 |